Communiqués BillionToOne, Inc.

Actions

BLLN

US0901681058

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 18/09/2026			Varia. 5j.	Varia. 1 janv.
105,92 ^USD	-4,29%		+7,24%	+29,42%

17/09	Un initié de BillionToOne a vendu des actions pour une valeur de 3 030 444 $, selon un récent dépôt auprès de la SEC	MT
14/09	Un initié de Billiontoone a vendu des actions pour une valeur de 1 975 400 $, selon une récente déclaration à la SEC	MT

Communiqués

05/08	BillionToOne: Q2 Earnings Snapshot	AQ
05/08	BillionToOne : Presentation (2f9443cf 74dd 419c b487 161224a7f0b6)	PU
05/08	BillionToOne : 2Q26 Earnings Presentation	PU
05/08	BillionToOne Reports Second Quarter 2026 Results and Reiterates 2026 Revenue Guidance	GL
05/08	BillionToOne Reports Second Quarter 2026 Results and Reiterates 2026 Revenue Guidance	AQ
15/07	BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026	GL
27/05	BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference	GL
06/05	BillionToOne: Q1 Earnings Snapshot	AQ
06/05	BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance	GL
06/05	BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance	AQ
04/05	BillionToOne Launches Unity Confirm: A category-defining test that bridges the gap between screening and invasive diagnostics	AQ
02/05	BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics	PR
15/04	BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026	GL
04/03	BillionToOne: Q4 Earnings Snapshot	AQ
04/03	BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance	GL
17/02	BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026	GL
16/01	BillionToOne Announces Collaboration with Epic to Expand Prenatal and Oncology Testing Across Healthcare	AQ
12/01	BillionToOne Provides Guidance for 2026	GL
23/12	BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference	GL
09/12	BillionToOne Reports Third Quarter 2025 Results	GL
02/12	BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025	GL
07/11	BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares	AQ